Literature DB >> 7445577

[Pharmacokinetics of caffeine in mice and its modification by ethanol].

M Hartmann, G Czok.   

Abstract

In experiments on mice the pharmacokinetics (absorption, distribution, metabolism) of orally administered caffeine (18 mg/kg) using 14C caffeine as marker and the influence of simultaneously applied ethanol (1,8 g/kg) was tested. The following results were obtained: 1. Caffeine was very quickly absorbed from the gastro-intestinal tract of mice. Addition of ethanol had no noticeable influence on the absorption of caffeine. 2. The elimination of caffeine from the serum and tissues examined (liver, kidney, brain, muscle) showed an exponential course with a half life of 40-60 minutes and was completed after 4 to 5 hours. 3. By giving ethanol the elimination of caffeine was significantly decreased and its half life increased to 160-240 minutes. 4. The caffeine metabolites reached their maximal concentration in serum and tissues examined within two hours. In the liver and kidney the concentration of caffeine metabolites was greater than in the serum, whereas they were lower in the brain and muscle. At the end of the experimental the concentration of caffeine metabolites reached only very low values. 5. After administration of ethanol the caffeine metabolites were significantly decreased from the 30th to 180th minute in the liver and kidney; they were only slightly lowered in the serum and almost unchanged in the muscle and brain. The results of these experiments suggest that ethanol inhibits the metabolism of caffeine in the liver, especially by influencing its demethylation to other dimethyl- and monomethylxanthines and probably also its oxidation ot methyluric acids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7445577     DOI: 10.1007/bf02018787

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  12 in total

1.  The fate of caffeine in man and a method for its estimation in biological material.

Authors:  J AXELROD; J REICHENTHAL
Journal:  J Pharmacol Exp Ther       Date:  1953-04       Impact factor: 4.030

2.  [Significance of caffeine in analgesic combined preparations].

Authors:  R WEIGMANN
Journal:  Arzneimittelforschung       Date:  1953-12

3.  Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene.

Authors:  A Aldridge; W D Parsons; A H Neims
Journal:  Life Sci       Date:  1977-10-01       Impact factor: 5.037

4.  Inhibition by caffeine of ethanol absorption in rats.

Authors:  C P Siegers; O Strubelt; G Back
Journal:  Eur J Pharmacol       Date:  1972-11       Impact factor: 4.432

5.  Urinary excretion of caffeine and its metabolites in the mouse.

Authors:  A W Burg; M E Stein
Journal:  Biochem Pharmacol       Date:  1972-04-01       Impact factor: 5.858

6.  Tissue distribution of caffeine and its metabolites in the mouse.

Authors:  A W Burg; E Werner
Journal:  Biochem Pharmacol       Date:  1972-04-01       Impact factor: 5.858

Review 7.  [Mutual effects of alcohol and drugs].

Authors:  K Soehring; R Schüppel
Journal:  Dtsch Med Wochenschr       Date:  1966-10-21       Impact factor: 0.628

8.  Identification, kinetic and quantitative study of [2-14C] and [1-Me-14C]caffeine metabolites in rat's urine by chromatographic separations.

Authors:  M J Arnaud
Journal:  Biochem Med       Date:  1976-08

9.  Potentiation of the anti-inflammatory and analgesic activity of aspirin by caffeine in the rat.

Authors:  R Vinegar; J F Truax; J L Selph; R M Welch; H L White; C H Ellis
Journal:  Proc Soc Exp Biol Med       Date:  1976-03

10.  Caffeine metabolism in the newborn.

Authors:  A Aldridge; J V Aranda; A H Neims
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

View more
  6 in total

1.  Voluntary exercise together with oral caffeine markedly stimulates UVB light-induced apoptosis and decreases tissue fat in SKH-1 mice.

Authors:  Yao-Ping Lu; Bonnie Nolan; You-Rong Lou; Qing-Yun Peng; George C Wagner; Allan H Conney
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

2.  Effects of Treatment With Hypnotics on Reduced Sleep Duration and Behavior Abnormalities in a Mouse Model of Fragile X Syndrome.

Authors:  Rachel Michelle Saré; Abigail Lemons; Carolyn Beebe Smith
Journal:  Front Neurosci       Date:  2022-06-02       Impact factor: 5.152

3.  [Modification of the caffeine metabolism in mouse liver slices by previous treatment of the experimental animals with ethanol, aminophenazone and phenobarbital].

Authors:  A Finke; G Czok
Journal:  Z Ernahrungswiss       Date:  1980-09

4.  Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice.

Authors:  Monica Aleman; Rui Zhang; Wei Feng; Lihong Qi; Jose R Lopez; Chelsea Crowe; Yao Dong; Genady Cherednichenko; Isaac N Pessah
Journal:  Mol Pharmacol       Date:  2020-08-06       Impact factor: 4.436

5.  [Reciprocal action between caffeine, other stimulants and drugs].

Authors:  G Czok
Journal:  Z Ernahrungswiss       Date:  1980-12

6.  Electrophysiological signatures of acute systemic lipopolysaccharide-induced inflammation: potential implications for delirium science.

Authors:  Ziyad W Sultan; Elizabeth R Jaeckel; Bryan M Krause; Sean M Grady; Caitlin A Murphy; Robert D Sanders; Matthew I Banks
Journal:  Br J Anaesth       Date:  2021-02-26       Impact factor: 9.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.